HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.065
Day range
$0.064 - $0.066
Year range
$0.050 - $0.13
Market cap
27.23M USD
Avg Volume
275.22K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 844.72K | 83.53% |
Net income | -1.31M | -29.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.17M | -54.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.98K | -60.00% |
Total assets | 419.90K | -47.65% |
Total liabilities | 6.59M | 5.82% |
Total equity | -6.17M | — |
Shares outstanding | 420.28M | — |
Price to book | -6.50 | — |
Return on assets | -511.23% | — |
Return on capital | 82.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.31M | -29.27% |
Cash from operations | -839.87K | -48.65% |
Cash from investing | — | — |
Cash from financing | 495.90K | -15.86% |
Net change in cash | -343.99K | -1,481.16% |
Free cash flow | -406.38K | 81.59% |
About
Founded
2002
Headquarters
Website
Employees
6
